Title: Assessing Clinical Trial Failure Risk Factors And Reasons In Gastric Cancer
Version: 1 Date: 20 Jul 2022
Reviewer's report:
The paper could be improved with tighter structural and English language editing.
The whole paper in my view should focus on the reasons for not completing studies,  comparing
this to what is known about cancer clinical trials across oncology, and for making reasonable
conclusions.
The conclusion as it is written is an overreach with respect to the suggested value of trials not
completed for "bad " reasons.
Title: Assessing Clinical Trial Failure Risk Factors And Reasons In Gastric Cancer
Version: 1 Date: 20 Jul 2022
Reviewer's report:
The paper could be improved with tighter structural and English language editing.
The whole paper in my view should focus on the reasons for not completing studies,  comparing
this to what is known about cancer clinical trials across oncology, and for making reasonable
conclusions.
The conclusion as it is written is an overreach with respect to the suggested value of trials not
completed for "bad " reasons.
Please review this paper.
user
Title: Assessing Clinical Trial Failure Risk Factors And Reasons In Gastric Cancer
Version: 1 Date: 20 Jul 2022
Reviewer's report:
The paper could be improved with tighter structural and English language editing.
The whole paper in my view should focus on the reasons for not completing studies,  comparing
this to what is known about cancer clinical trials across oncology, and for making reasonable
conclusions.
The conclusion as it is written is an overreach with respect to the suggested value of trials not
completed for "bad " reasons.
assistant